Reproducibility of a symptom response to omeprazole therapy in functional dyspepsia evaluated by a random-starting-day trial design

Alimentary Pharmacology and Therapeutics

Volumn 20, Issue 3, 2004, Pages 365-372

  Madsen, L G ^a   Bytzer, P ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PLACEBO;

ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; DYSPEPSIA; EPIGASTRIC PAIN; FEMALE; FUNCTIONAL DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RELAPSE; REPRODUCIBILITY; SCORING SYSTEM; SELF REPORT; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; DYSPEPSIA; FEMALE; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; REPRODUCIBILITY OF RESULTS;

EID: 4043123212     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.02072.x     Document Type: Article

References (32)

1. Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Irritable Bowel Syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995; 109: 671-80.
2. Jones R, Lydeard S. Prevalence of symptoms of dyspepsia in the community. BMJ 1989; 298: 30-2.
3. Jones R, Lydeard S. Dyspepsia in the community: a follow-up study. Br J Clin Pract 1992; 46: 95-7.
4. Kay L, Jorgensen T. Epidemiology of upper dyspepsia in a random population. Prevalence, incidence, natural history, and risk factors. Scand J Gastroenterol 1994; 29: 2-6.
5. Bytzer P, Talley NJ. Dyspepsia. Ann Intern Med 2001; 134: 815-22.
6. Joffe SN, Primrose JN. Pain provocation test in peptic duodenitis. Gastrointest Endosc 1983; 29: 282-4.
7. Kang JY, Yap I, Guan R, Tay HH. Acid perfusion of duodenal ulcer craters and ulcer pain: a controlled double blind study. Gut 1986; 27: 942-5.
8. Kang JY, Yap I, Guan R, Tay HH, Math MV. Acid induced duodenal ulcer pain: the influence of symptom status and the effect of an antispasmodic. Gut 1989; 30: 166-70.
9. McColl KE, Fullarton GM. Duodenal ulcer pain - the role of acid and inflammation. Gut 1993; 34: 1300-2.
10. Bates S, Sjoden PO, Fellenius J, Nyren O. Blocked and non-blocked acid secretion and reported pain in ulcer, nonulcer dyspepsia, and normal subjects. Gastroenterology 1989; 97: 376-83.
11. Karnad DR, Abraham P, Rathod NM, Nazareth HM. Test for H2 -antagonist response in non-ulcer dyspepsia. Lancet 1990; 335: 657-8.
12. Son HJ, Rhee PL, Kim JJ, et al. Hypersensitivity to acid in ulcer-like functional dyspepsia. Korean J Intern Med 1997; 12: 188-92.
13. Samsom M, Verhagen MA, vanBerge Henegouwen GP, Smout AJ. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology 1999; 116: 515-20.
14. Schwartz MP, Samsom M, Berge Henegouwen GP, Smout AJ. Effect of inhibition of gastric acid secretion on antropyloroduodenal motor activity and duodenal acid hypersensitivity in functional dyspepsia. Aliment Pharmacol Ther 2001; 15: 1921-8.
15. Veldhuyzen-van Zanten S, Talley NJ, Bytzer P, et al. Design of treatment trials for functional gastrointestinal disorders. Gut 1999; 45(Suppl. 2): II69-77.
16. Madsen LG, Bytzer P. Review article: Single subject trials as a research instrument in gastrointestinal pharmacology. Aliment Pharmacol Ther 2002; 16: 189-96.
17. Bytzer P, Hansen JM, Rune S, et al. Identifying responders to acid suppression in dyspepsia using a random starting day trial. Aliment Pharmacol Ther 2000; 11: 1485-94.
18. Madsen LG, Wallin L, Bytzer P. Identifying response to acid suppressive therapy in functional dyspepsia using a Random Starting Day trial - is gastro-oesophageal reflux important? Aliment Pharmacol Ther 2004 (in press).
19. Veldhuyzen-van Zanten SJO, Tytgat KMAJ, Pollak PT, et al. Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis? Journal of Clinical Epidemiology 1993; 46: 273-9.
20. Altman D. Practical statistics for medical research. London: Chapman & Hall, 1991.
21. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992; 136: 165-77.
22. Johannessen T, Petersen H, Kristensen P, et al. The intensity and variability of symptoms in dyspepsia. Scandinavian Journal of Primary Health Care 1993; 11: 50-5.
23. Sandha GS, Hunt RH, Veldhuyzen van Zanten SJ. A systematic overview of the use of diary cards, quality-of-life questionnaires, and psychometric tests in treatment trials of Vlelicobacter pylori-positive and -negative non-ulcer dyspepsia. Scand J Gastroenterol 1999; 34: 244-9.
24. Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR. Patient non-compliance with paper diaries. BMJ 2002; 324: 1193-4.
25. Johnsson F, Weywadt L, Solhaug JH, Hernqvist H, Bengtsson L. One-week omeprazole treatment in the diagnosis of gastrooesophageal reflux disease. Scand J Gastroenterol 1998; 33: 15-20.
26. Johnsson F, Hatlebakk JG, Klintenberg AC, et al. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease. Scand J Gastroenterol 2003; 38: 354-9.
27. 7 Armstrong D, Veldhuyzen-van Zanten SJO, Barkun AN, et al. An acid supression test using esomeprazole (40 mg BID and OD) in uninvestigated patients with heartburn or non-heart-burn-dominant dyspepsia. Gut 2003; 52(Suppl. VI): A139.
28. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 1997; 92: 1997-2000.
29. Fass R, Ofman JJ, Gralnek IM, et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med 1999; 159: 2161-8.
30. Spiegelhalter DJ. Statistical issues in studies of individual response. Scand J Gastroenterol Suppl 1988; 147: 40-5.
31. Johannessen T, Fosstvedt D, Petersen H. Experience with a multi crossover model in dyspepsia. Scand J Gastroenterol Suppl 1988; 147: 33-7.
32. Madsen LG, Hansen JH, Darholdt A, Groenvold M, Bytzer P. Validation of a dyspepsia symptom rating scale through assessment of patient-observer agreement combining results from interview and diary ratings. Gastroenterology 2004; 126(Suppl. 2): A438.